Company / Current Liabilities
LENZ Therapeutics, Inc. Current Liabilities History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$21.2M
FY2025
5-year range
$10.4M / $21.2M
FY2021-FY2025
Trend
+103.6%
vs FY2024
Sector context
#188 of 213
Health Care
What the data says
LENZ Therapeutics, Inc.'s current liabilities of $21M is lower than 88% of companies in the Health Care sector (FY2025). Current Liabilities has fluctuated over the past 6 years, ranging from $10M in FY2024 to $32M in FY2020.
Based on SEC 10-K filings.
$21M in FY2025 with a 5-year CAGR of -7.9%.
Increased from $19M to $21M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +17.6%
- 5-Year CAGR
- -7.9%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 213This company $21.2M Sector average $1.6B
▼
-98.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -7.9%, indicating a declining trend.
- In FY2025, current liabilities increased 103.6% year-over-year.
- Ranks #188 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.2M | +103.6% |
| FY2024 | $10.4M | -43.8% |
| FY2023 | $18.5M | +41.9% |
| FY2022 | $13.0M | +7.4% |
| FY2021 | $12.1M | -62.1% |
| FY2020 | $32.0M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026